Tue 20 Oct 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
| Scientific Name | Trade Name | Updated Section | Month |
|---|---|---|---|
| Liraglutide | Saxenda | 4.8 Undesirable effects | Oct,2023 |
| Tirzepatide | Mounjaro | 4.8 Undesirable effects | Oct,2023 |
| Semaglutide | Ozempic | 4.8 Undesirable effects | Oct,2023 |
| Semaglutide | Rybelsus | 4.8 Undesirable effects | Oct,2023 |
| Dexketoprofen | Ketesse | 4.6. Fertility, pregnancy and lactation | Oct,2022 |
| Lansoprazole | Lanzor | 4.4. Special warnings and precautions for use | Oct,2022 |
| Dolutegravir, Lamivudine | Dovato | 4.8. Undesirable effects | Oct,2022 |
| Topiramate | Topamax | 4.4. Special warnings and precautions for use | Oct,2022 |
| Canagliflozin | Invokana | 4.5. Interactions with other medicinal products | Oct,2022 |
| Ertugliflozin, Metformin Hydrochloride | Segluromet | 4.5. Interactions with other medicinal products | Oct,2022 |
Last update date: 04/10/2026 at 10:24 AM Saudi Arabia time
No feedback has been submitted for this page yet.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.